Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for healthcare industry professionals · Monday, October 22, 2018 · 465,736,493 Articles · 3+ Million Readers
Home  •••  Topics  •  Countries  •  U.S. States  •  World Media Directory  •  Events
Wellness News  •••  Topics  •  Countries  •  U.S. States  •  Events

Guinea-Bissau Wellness News Monitoring Service

No articles found


Featured Releases

Got News to Share? · Submit · See All

Load more wellness news or search news using your own keywords. There are 465,736,493 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Submit News & Events

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

Have an event? Add it to our Events & Conferences Directory.

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 10/22/2018

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Healthcare & Pharmaceuticals Events

Got Events to Share? · Submit · See All

Global Regulatory Affairs Summit

Date: 23-Oct-18 to 25-Oct-18
Location: Berlin / Germany
Whatever your international hurdle, our industry and authority experts have the answers...

Genotoxic Impurities

Date: 23-Oct-18 to 24-Oct-18
Location: Berlin / Germany
The brightest industry and regulatory minds shine a light on identification and control of GTIs. Build a complete strategy for potential genotoxic impurities in your pharmaceuticals.

eyeforpharma Patient Summit USA

Date: 23-Oct-18 to 24-Oct-18
Patient value has now become synonymous with business value. Companies listening to the growing patient voice and incorporating those insights into the design of products, trials and strategy are being rewarded with higher uptake and better outcomes. Patients are no longer just recipients of care, they are also active partners in the design and masters of their own care decisions. Fortunately for pharma, it’s never been easier to speak to patients. Digital avenues, social media engaged advocacy groups and, most importantly, a receptive audience means pharma has the opportunity and the technology to interact with patients and build what they want. Opportunities are aplenty for those willing to walk the talk on patient engagement. Are you a walker or a talker?

Targeted Protein Degradation Summit

Date: 23-Oct-18 to 25-Oct-18
Location: Boston / United States
As the drug discovery opportunity hidden within the proteome opens up and gains tremendous investment, the inaugural Targeted Protein Degradation Summit 2018 is a dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to capitalize on this emerging therapeutic class. Focus on understanding the selectivity and speed of binding, improve the rationale design of bifunctional molecules and overcome critical chemistry challenges to translate these unique small molecules into safe and effective clinical therapeutics. Built with large pharma and biotech insight, the TPD 2018 is specifically focused on optimizing and accelerating the discovery, translational research and ultimately clinical development of targeted protein degradation therapies ...

Immune Checkpoint Inhibitors in the Treatment of Stage III NSCLC, Oct 23

Date: 23-Oct-18 to 23-Oct-18
Location: Orlando / United States
Join us on Tuesday, October 23 at the Orlando World Center Marriott for a clinic-focused symposium during AMCP Nexus 2018. Explore the pharmacist’s critical role in the optimal integration of checkpoint inhibitors into the care of patients with unresectable stage III NSCLC at this dynamic satellite. Attendees will have the opportunity to text questions to expert faculty, Ali McBride, PharmD, MS, BCOP, FAzPA; Sandra Cuellar, PharmD, BCOP; and Tarek M. Mekhail, MD, MSc, FRCSI, FRCSEd, and get practical guidance on the application of immunotherapy approaches to early-stage NSCLC. This satellite symposium is complimentary to attend and is ACPE-certified for 1.5 contact hours. For more information and to register, go to https://events.clinicaloptions.com/oncology/Nexus2018.

Assessing RET-Altered Tumors for Personalized Oncology Care, Oct 23

Date: 23-Oct-18 to 23-Oct-18
Location: Chicago / United States
Join us on Tuesday, October 23 at the Hyatt Regency in Chicago for a dynamic symposium during CAP 2018. Learn about the latest clinical data on selective RET inhibitors along with practical guidance to facilitate the detection of RET alterations from leading pathology experts, Dara L. Aisner, MD, PhD, and Eric Q. Konnick, MD, MS. They will lead discussions and answer your questions on the methodology and testing strategies for RET fusions and mutations.. This satellite symposium is complimentary to attend and is CME-certified for 1.5 contact hours.

CMHC 13th Annual Boston 2018 | Boston, MA

Date: 24-Oct-18 to 27-Oct-18
Location: United States
More than one-third of the population has at least one cardiometabolic risk factor - dyslipidemia, CVD, hypertension, diabetes, and/or obesity. Now in its 13th year, the Cardiometabolic Health Congress is the largest, US-based, multidisciplinary conference focused solely on the management of cardiometabolic risk and the prevention of cardiovascular and metabolic disease. The 3 ½- day event offers today's busy healthcare professionals a one-of-a-kind opportunity to learn real-world solutions they can integrate immediately into their clinical practices. For sponsorship/exhibitor opportunities, please contact kathleen@cardiometabolichealth.org

Tailoring Treatment of EGFR-Mutated NSCLC to Improve Patient Care, Oct 24

Date: 24-Oct-18 to 24-Oct-18
Location: Orlando / United States
Join us on Wednesday, October 24 at the Orlando World Center Marriott for this interactive symposium where pharmacy and oncology experts Val R. Adams, PharmD, FCCP, BCOP; Edward S. Kim, MD, FACP; and Philip Schwieterman, PharmD, MHA, provide their perspectives on the role of EGFR-targeted therapies in the management of patients with advanced EGFR-mutated NSCLC, including insights into the latest first-line and second-line clinical data and how pharmacists can safely and effectively apply these new practice-changing data into care plans for their patients. This satellite symposium is complimentary to attend and is ACPE-certified for 1.5 contact hours. For more information and to register, visit our site here: https://events.clinicaloptions.com/oncology/Nexus2018.

Immunology of Diabetes Society Congress 2018

Date: 25-Oct-18 to 29-Oct-18
Location: London / United Kingdom
The organising committee for the 16th Immunology of Diabetes Society Congress would like to invite participants to this exciting meeting. We have arranged talks on a wide range of current topics of interest to the community, which include ground-breaking technologies, cell-based and advanced therapeutics, immmunopathology of type 1 diabetes, pathways to beta cell failure, updates from the Networks – nPod, TEDDY, Trialnet and the Immune Tolerance Network, as well as an adversarial debate and a “balloon debate”. There will be ample opportunities for networking and discussion, to move towards our common goal of understanding the immunology of type 1 diabetes and how we may intervene to change the course of disease. We hope you will join us at the QEII in the heart of London, where you ...